Net Income (Loss) Attributable to Parent in USD of Medpace Holdings, Inc. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Medpace Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2015 to Q3 2025.
  • Medpace Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $111,135,000.000, a 15.3% increase year-over-year.
  • Medpace Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $433,008,000.000, a 18.4% increase year-over-year.
  • Medpace Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $404,386,000.000, a 43% increase from 2023.
  • Medpace Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $282,810,000.000, a 15.3% increase from 2022.
  • Medpace Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $245,368,000.000, a 34.9% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $433,008,000 $111,135,000 +$14,709,000 +15.3% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025
Q2 2025 $418,299,000 $90,260,000 +$1,909,000 +2.2% 01 Apr 2025 30 Jun 2025 10-Q 23 Oct 2025
Q1 2025 $416,390,000 $114,595,000 +$12,004,000 +11.7% 01 Jan 2025 31 Mar 2025 10-Q 23 Oct 2025
Q4 2024 $404,386,000 $117,018,000 +$38,720,000 +49.5% 01 Oct 2024 31 Dec 2024 10-K 11 Feb 2025
Q3 2024 $365,666,000 $96,426,000 +$25,876,000 +36.7% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025
Q2 2024 $339,790,000 $88,351,000 +$27,283,000 +44.7% 01 Apr 2024 30 Jun 2024 10-Q 23 Oct 2025
Q1 2024 $312,507,000 $102,591,000 +$29,697,000 +40.7% 01 Jan 2024 31 Mar 2024 10-Q 23 Oct 2025
Q4 2023 $282,810,000 $78,298,000 +$9,628,000 +14% 01 Oct 2023 31 Dec 2023 10-K 11 Feb 2025
Q3 2023 $273,182,000 $70,550,000 +$4,523,000 +6.8% 01 Jul 2023 30 Sep 2023 10-Q 22 Oct 2024
Q2 2023 $268,659,000 $61,068,000 +$11,708,000 +23.7% 01 Apr 2023 30 Jun 2023 10-Q 22 Oct 2024
Q1 2023 $256,951,000 $72,894,000 +$11,583,000 +18.9% 01 Jan 2023 31 Mar 2023 10-Q 22 Oct 2024
Q4 2022 $245,368,000 $68,670,000 +$18,636,000 +37.2% 01 Oct 2022 31 Dec 2022 10-K 11 Feb 2025
Q3 2022 $226,732,000 $66,027,000 +$17,453,000 +35.9% 01 Jul 2022 30 Sep 2022 10-Q 24 Oct 2023
Q2 2022 $209,279,000 $49,360,000 +$9,426,000 +23.6% 01 Apr 2022 30 Jun 2022 10-Q 24 Oct 2023
Q1 2022 $199,853,000 $61,311,000 +$18,005,000 +41.6% 01 Jan 2022 31 Mar 2022 10-Q 24 Oct 2023
Q4 2021 $181,848,000 $50,034,000 -$832,000 -1.6% 01 Oct 2021 31 Dec 2021 10-K 13 Feb 2024
Q3 2021 $182,680,000 $48,574,000 +$7,114,000 +17.2% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022
Q2 2021 $175,566,000 $39,934,000 +$15,830,000 +65.7% 01 Apr 2021 30 Jun 2021 10-Q 25 Oct 2022
Q1 2021 $159,736,000 $43,306,000 +$14,352,000 +49.6% 01 Jan 2021 31 Mar 2021 10-Q 25 Oct 2022
Q4 2020 $145,384,000 $50,866,000 +$21,053,000 +70.6% 01 Oct 2020 31 Dec 2020 10-K 14 Feb 2023
Q3 2020 $124,331,000 $41,460,000 +$17,483,000 +72.9% 01 Jul 2020 30 Sep 2020 10-Q 26 Oct 2021
Q2 2020 $106,848,000 $24,104,000 -$3,351,000 -12.2% 01 Apr 2020 30 Jun 2020 10-Q 26 Oct 2021
Q1 2020 $110,199,000 $28,954,000 +$9,756,000 +50.8% 01 Jan 2020 31 Mar 2020 10-Q 26 Oct 2021
Q4 2019 $100,443,000 $29,813,000 +$7,052,000 +31% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2020
Q3 2019 $93,391,000 $23,977,000 +$4,672,000 +24.2% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020
Q2 2019 $88,719,000 $27,455,000 +$10,887,000 +65.7% 01 Apr 2019 30 Jun 2019 10-Q 27 Oct 2020
Q1 2019 $77,832,000 $19,198,000 +$4,647,000 +31.9% 01 Jan 2019 31 Mar 2019 10-Q 27 Oct 2020
Q4 2018 $73,185,000 $22,761,000 +$11,470,000 +1% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2020
Q3 2018 $61,715,000 $19,305,000 +$9,474,000 +96.4% 01 Jul 2018 30 Sep 2018 10-K 25 Feb 2020
Q2 2018 $52,241,000 $16,568,000 +$7,015,000 +73.4% 01 Apr 2018 30 Jun 2018 10-K 25 Feb 2020
Q1 2018 $45,226,000 $14,551,000 +$6,104,000 +72.3% 01 Jan 2018 31 Mar 2018 10-K 25 Feb 2020
Q4 2017 $39,122,000 $11,291,000 +$11,312,000 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2019
Q3 2017 $27,810,000 $9,831,000 +$4,795,000 +95.2% 01 Jul 2017 30 Sep 2017 10-K 26 Feb 2019
Q2 2017 $23,015,000 $9,553,000 +$4,591,000 +92.5% 01 Apr 2017 30 Jun 2017 10-K 26 Feb 2019
Q1 2017 $18,424,000 $8,447,000 +$4,999,000 +1.4% 01 Jan 2017 31 Mar 2017 10-K 26 Feb 2019
Q4 2016 $13,425,000 -$21,000* +$8,555,000 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 $4,870,000 $5,036,000 +$5,169,000 01 Jul 2016 30 Sep 2016 10-K 27 Feb 2018
Q2 2016 -$299,000 $4,962,000 +$4,867,000 +51.2% 01 Apr 2016 30 Jun 2016 10-K 27 Feb 2018
Q1 2016 -$5,166,000 $3,448,000 +$3,507,000 01 Jan 2016 31 Mar 2016 10-K 27 Feb 2018
Q4 2015 -$8,673,000 -$8,576,000 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2017
Q3 2015 -$133,000 01 Jul 2015 30 Sep 2015 10-K 28 Feb 2017
Q2 2015 $95,000 01 Apr 2015 30 Jun 2015 10-K 28 Feb 2017
Q1 2015 -$59,000* 01 Jan 2015 31 Mar 2015 10-K 28 Feb 2017

Medpace Holdings, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $404,386,000 +$121,576,000 +43% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2025
2023 $282,810,000 +$37,442,000 +15.3% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2025
2022 $245,368,000 +$63,520,000 +34.9% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025
2021 $181,848,000 +$36,464,000 +25.1% 01 Jan 2021 31 Dec 2021 10-K 13 Feb 2024
2020 $145,384,000 +$44,941,000 +44.7% 01 Jan 2020 31 Dec 2020 10-K 14 Feb 2023
2019 $100,443,000 +$27,258,000 +37.2% 01 Jan 2019 31 Dec 2019 10-K 15 Feb 2022
2018 $73,185,000 +$34,063,000 +87.1% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $39,122,000 +$25,697,000 +1.9% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $13,425,000 +$22,098,000 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019
2015 -$8,673,000 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.